Clinical Trial

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Name: Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP) — clinical trial record (NCT07063199)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of Anti-CD38 Antibody in the treatment of elderly patients with primary immune thrombocytopenia in patients who have failed multiple treatment.

Trial Details

NCT Number	NCT07063199
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Immune Thrombocytopenia, Treatment
Enrollment	30 participants
Start Date	2025-08
Primary Completion	2026-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2025-07-14